Restatement of Previously Reported Financial Statements (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Changes and Error Corrections [Abstract]

Summary of Effect of Correcting Error in Balance Sheets

The following table presents the effect of correcting this error on the Company’s balance sheet as of December 31, 2023:

	December 31, 2023
	As Previously Reported			Restatement Impact			As Restated
Assets
Current Assets:
Cash and cash equivalents	$	4,739,426		$	—		$	4,739,426
Accounts receivable, net		673,071			—			673,071
Prepaid expenses		885,040			—			885,040
Inventory		481,840			—			481,840
Other current assets		47,532			—			47,532
Total current assets		6,826,909			—			6,826,909
Deferred offering costs		241,637			—			241,637
Total assets	$	7,068,546		$	—		$	7,068,546
Liabilities and stockholders' deficit
Current Liabilities:
Accounts payable and accrued expenses	$	1,711,778		$	—		$	1,711,778
Accrued compensation		1,324,010			—			1,324,010
Note Payable		—			5,000,000			5,000,000
Accrued interest payable		—			1,612,295			1,612,295
Total current liabilities		3,035,788			6,612,295			9,648,083
Long-term liabilities
Note payable		5,000,000			(5,000,000	)		—
Accrued interest payable		1,612,295			(1,612,295	)		—
Total long-term liabilities		6,612,295			(6,612,295	)		—
Total liabilities		9,648,083			—			9,648,083
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.0001 par value; authorized   shares - 5,000,000; issued and outstanding    shares - 0 at December 31, 2023		—			—			—
Common stock, $0.0001 par value; authorized  shares - 50,000,000; issued and outstanding  shares - 3,343,070 at December 31, 2023		334			—			334
Additional paid-in capital		120,859,567			—			120,859,567
Accumulated deficit		(123,439,438	)		—			(123,439,438	)
Total stockholders' deficit		(2,579,537	)		—			(2,579,537	)
Total liabilities and stockholders' deficit	$	7,068,546		$	—		$	7,068,546